World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02634450
Date of registration: 05/12/2015
Prospective Registration: No
Primary sponsor: Instituto Nacional de Saúde, Mozambique
Public title: Early Infant Diagnosis Point of Care Pilot
Scientific title: Evaluation of Point-Of-Care Testing Assays for Early Infant in Mozambique-Cluster Randomised Trial
Date of first enrolment: September 2015
Target sample size: 179
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02634450
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Mozambique
Contacts
Key inclusion & exclusion criteria

Inclusion Criteria:

- Born to HIV positive mother

- From 4 weeks to 18 months of age

- Came to CCR consultation for Early Infant Diagnosis

Exclusion Criteria:

- With a valid positive test by other center



Age minimum: N/A
Age maximum: 18 Months
Gender: All
Health Condition(s) or Problem(s) studied
HIV
Intervention(s)
Device: Alere q
Primary Outcome(s)
the proportion of HIV-positive infants who initiated antiretroviral therapy that were retained in care at 90 days of follow-up. [Time Frame: 3 months after treatment initiation]
The proportion of HIV-positive infants initiating antiretroviral therapy within 60 days of sample collection [Time Frame: up to 6 months]
Secondary Outcome(s)
The median age at time of results received by patient [Time Frame: Up to 6 months]
The median number of days between specimen collection and results received by patient [Time Frame: Up to 6 months]
The median age at time of antiretroviral treatment initiation [Time Frame: Up to 6 months]
The median number of days between specimen collection and initiation of antiretroviral treatment. [Time Frame: Up to 6 months]
Secondary ID(s)
POC EID PILOT
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
UNITAID
UNICEF
Clinton Health Access Initiative, Mozambique
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history